MSB 3.16% $1.31 mesoblast limited

Ann: FDA Clears Phase 3 Heart Failure Trial , page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,101 Posts.
    lightbulb Created with Sketch. 218
    Bitter sweet for me. Sweet I just recouped $$thousands of losses and bitter because my damn buy in price was 6.70 ;-)

    LOL Which is totally going to be about the top of this revival I think.

    I suspect the trading range will end up being 6.50-7.10.

    Will have a pull back of 20-30cents in the next week or so.

    I knew I should have doubled down in the low 5.00's....but my gambling streek was dormant. For now I'll just load up on dips as others have suggested and think long long term.

    Cheers for the optimism Vinn and others. But to be a black hat/contrarian....

    This ANN *was* expected. They had said all along CHF3 would go ahead. The fact the FDA passed it through real quick is awesome but from my POV at least it was well expected this would occur.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.